These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
791 related articles for article (PubMed ID: 29207133)
1. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics. Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data. Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405 [TBL] [Abstract][Full Text] [Related]
4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
5. Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database. Yan HB; Huang JC; Chen YR; Yao JN; Cen WN; Li JY; Jiang YF; Chen G; Li SH Pathol Res Pract; 2018 Feb; 214(2):195-206. PubMed ID: 29258768 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
7. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
8. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Chi Q; Geng X; Xu K; Wang C; Zhao H Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629 [TBL] [Abstract][Full Text] [Related]
9. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149 [TBL] [Abstract][Full Text] [Related]
10. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665 [TBL] [Abstract][Full Text] [Related]
11. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis. Tang Y; Zhang Y; Hu X Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119 [TBL] [Abstract][Full Text] [Related]
13. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
14. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma. Zhai X; Xue Q; Liu Q; Guo Y; Chen Z Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses. Liu AG; Pang YY; Chen G; Wu HY; He RQ; Dang YW; Huang ZG; Zhang R; Ma J; Yang LH Technol Cancer Res Treat; 2020; 19():1533033820979670. PubMed ID: 33327879 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance. Ding H; Ye ZH; Wen DY; Huang XL; Zeng CM; Mo J; Jiang YQ; Li JJ; Cai XY; Yang H; Chen G Mol Med Rep; 2017 Oct; 16(4):5393-5405. PubMed ID: 28849100 [TBL] [Abstract][Full Text] [Related]
17. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network. Yan L; Yue C; Xu Y; Jiang X; Zhang L; Wu J Med Sci Monit; 2020 May; 26():e921895. PubMed ID: 32457285 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing. Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]